Interest Expense in USD of Propanc Biopharma, Inc. from Q4 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Propanc Biopharma, Inc. quarterly/annual Interest Expense history and change rate from Q4 2010 to Q1 2024.
  • Propanc Biopharma, Inc. Interest Expense for the quarter ending 31 Mar 2024 was $133K, a 15.3% decline year-over-year.
  • Propanc Biopharma, Inc. Interest Expense for the twelve months ending 31 Mar 2024 was $690K, a 29.7% increase year-over-year.
  • Propanc Biopharma, Inc. annual Interest Expense for 2023 was $533K, a 6.33% decline from 2022.
  • Propanc Biopharma, Inc. annual Interest Expense for 2022 was $569K, a 26.6% increase from 2021.
  • Propanc Biopharma, Inc. annual Interest Expense for 2021 was $449K, a 74.3% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Propanc Biopharma, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $690K $133K -$24.1K -15.3% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $714K $264K +$166K +168% 01 Oct 2023 31 Dec 2023 10-Q 20 Feb 2024
Q3 2023 $548K $178K +$15.5K +9.51% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $533K $114K +$577 +0.51% 01 Apr 2023 30 Jun 2023 10-K 28 Sep 2023
Q1 2023 $532K $157K -$10.2K -6.07% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 $542K $98.6K -$79.3K -44.6% 01 Oct 2022 31 Dec 2022 10-Q 20 Feb 2024
Q3 2022 $622K $163K +$52.9K +48.2% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $569K $114K +$84.2K +286% 01 Apr 2022 30 Jun 2022 10-K 28 Sep 2023
Q1 2022 $485K $167K +$64.5K +62.7% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 $420K $178K +$20.1K +12.7% 01 Oct 2021 31 Dec 2021 10-Q 10 Feb 2023
Q3 2021 $400K $110K -$49.4K -31% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $449K $29.4K -$213K -87.8% 01 Apr 2021 30 Jun 2021 10-K 28 Sep 2022
Q1 2021 $662K $103K -$282K -73.3% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 $944K $158K -$288K -64.6% 01 Oct 2020 31 Dec 2020 10-Q 14 Feb 2022
Q3 2020 $1.23M $159K -$516K -76.4% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 $1.75M $242K +$237K +4556% 01 Apr 2020 30 Jun 2020 10-K 28 Sep 2021
Q1 2020 $1.51M $385K +$195K +103% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021
Q4 2019 $1.32M $446K -$48.9K -9.88% 01 Oct 2019 31 Dec 2019 10-Q 12 Feb 2021
Q3 2019 $1.37M $675K +$50.7K +8.12% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020
Q2 2019 $1.31M $5.2K -$574K -99.1% 01 Apr 2019 30 Jun 2019 10-K 01 Oct 2020
Q1 2019 $1.89M $190K -$641K -77.2% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q4 2018 $2.53M $495K +$8.24K +1.69% 01 Oct 2018 31 Dec 2018 10-Q 14 Feb 2020
Q3 2018 $2.52M $625K -$268K -30% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 $2.79M $579K -$98.3K -14.5% 01 Apr 2018 30 Jun 2018 10-K 15 Oct 2019
Q1 2018 $2.89M $831K +$32.6K +4.08% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 $2.85M $487K -$769K -61.2% 01 Oct 2017 31 Dec 2017 10-Q 14 Feb 2019
Q3 2017 $3.62M $892K +$421K +89.3% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018
Q2 2017 $3.2M $677K -$1.13M -62.5% 01 Apr 2017 30 Jun 2017 10-K 17 Sep 2018
Q1 2017 $4.33M $798K -$306K -27.7% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018
Q4 2016 $4.64M $1.26M +$100K +8.65% 01 Oct 2016 31 Dec 2016 10-Q 09 Feb 2018
Q3 2016 $4.54M $471K +$52.7K +12.6% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q2 2016 $4.49M $1.81M +$1.33M +280% 01 Apr 2016 30 Jun 2016 10-K 28 Sep 2017
Q1 2016 $3.15M $1.1M +$905K +454% 01 Jan 2016 31 Mar 2016 10-Q 08 May 2017
Q4 2015 $2.25M $1.16M +$1.06M +1054% 01 Oct 2015 31 Dec 2015 10-Q 14 Feb 2017
Q3 2015 $1.19M $419K -$130K -23.7% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016
Q2 2015 $1.32M $476K +$425K +836% 01 Apr 2015 30 Jun 2015 10-K 28 Sep 2016
Q1 2015 $899K $199K +$179K +901% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016
Q4 2014 $719K $100K +$80K +395% 01 Oct 2014 31 Dec 2014 10-Q 16 Feb 2016
Q3 2014 $639K $548K +$546K +25234% 01 Jul 2014 30 Sep 2014 10-Q 16 Nov 2015
Q2 2014 $93.1K $50.9K +$49.4K +3376% 01 Apr 2014 30 Jun 2014 10-K 30 Sep 2015
Q1 2014 $43.8K $19.9K +$18.5K +1344% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015
Q4 2013 $25.2K $20.2K +$19K +1617% 01 Oct 2013 31 Dec 2013 10-Q 17 Feb 2015
Q3 2013 $6.18K $2.17K +$719 +49.7% 01 Jul 2013 30 Sep 2013 10-Q 19 Nov 2014
Q2 2013 $5.47K $1.46K +$174K 01 Apr 2013 30 Jun 2013 10-K 14 Oct 2014
Q1 2013 -$169K $1.38K +$307 +28.7% 01 Jan 2013 31 Mar 2013 10-Q 20 May 2014
Q4 2012 -$169K $1.18K +$564 +91.9% 01 Oct 2012 31 Dec 2012 10-Q 14 Feb 2014
Q3 2012 -$170K $1.45K -$173K -99.2% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013
Q2 2012 $2.97K -$173K 01 Apr 2012 30 Jun 2012 10-K 15 Oct 2013
Q1 2012 $1.07K 01 Jan 2012 31 Mar 2012 10-Q 20 May 2013
Q4 2011 $614 +$614 01 Oct 2011 31 Dec 2011 10-Q 20 Feb 2013
Q3 2011 $174K 01 Jul 2011 30 Sep 2011 10-Q 19 Nov 2012
Q4 2010 $0 01 Oct 2010 31 Dec 2010 10-Q/A 07 Mar 2012

Propanc Biopharma, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $533K -$36K -6.33% 01 Jul 2022 30 Jun 2023 10-K 28 Sep 2023
2022 $569K +$119K +26.6% 01 Jul 2021 30 Jun 2022 10-K 28 Sep 2023
2021 $449K -$1.3M -74.3% 01 Jul 2020 30 Jun 2021 10-K 28 Sep 2022
2020 $1.75M +$434K +33% 01 Jul 2019 30 Jun 2020 10-K 28 Sep 2021
2019 $1.31M -$1.47M -52.9% 01 Jul 2018 30 Jun 2019 10-K 01 Oct 2020
2018 $2.79M -$414K -12.9% 01 Jul 2017 30 Jun 2018 10-K 15 Oct 2019
2017 $3.2M -$1.28M -28.6% 01 Jul 2016 30 Jun 2017 10-K 17 Sep 2018
2016 $4.49M +$3.16M +239% 01 Jul 2015 30 Jun 2016 10-K 28 Sep 2017
2015 $1.32M +$1.23M +1321% 01 Jul 2014 30 Jun 2015 10-K 28 Sep 2016
2014 $93.1K +$87.7K +1604% 01 Jul 2013 30 Jun 2014 10-K 30 Sep 2015
2013 $5.47K +$2.5K +84.2% 01 Jul 2012 30 Jun 2013 10-K 14 Oct 2014
2012 $2.97K 01 Jul 2011 30 Jun 2012 10-K 15 Oct 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.